Filtros de búsqueda

Lista de obras de

Anticancer effects of the microbiome and its products

artículo científico

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

artículo científico publicado en 2015

COVID-19: a challenge for oncology services

scientific article published on 05 May 2020

Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer

scientific article published on 25 May 2020

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

artículo científico publicado en 2020

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors

scientific article published on 20 July 2020

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

artículo científico publicado en 2016

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

artículo científico publicado en 2017

Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients

artículo científico publicado en 2020

Immunodynamics of explanted human tumors for immuno-oncology

artículo científico publicado en 2020

Immunological off-target effects of imatinib

artículo científico publicado en 2016

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment

artículo científico publicado en 2021

Microbiome and Anticancer Immunosurveillance

artículo científico publicado en 2016

Prime time for immune-checkpoint targeted therapy at ASCO 2015

artículo científico publicado en 2016

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

artículo científico publicado en 2021

Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

artículo científico publicado en 2016

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer

scientific article published on 11 October 2017

The gut microbiota influences anticancer immunosurveillance and general health

artículo científico publicado en 2018

The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1

scholarly article by Lisa Derosa et al published 2018 in OncoImmunology

The intimate relationship between gut microbiota and cancer immunotherapy

scholarly article by Arielle Elkrief et al published 19 October 2018 in Gut microbes

Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

scientific article published on 03 June 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda